Developer docs
API playgroundTry for free, no card

Search company profiles

eSight

Full company profile

uuid0000uhm

Namestring
eSight
Legal namestring
eSight Corp
Company typeenum
Private
Founded yearint
2013
Descriptiontext

eSight Corp is a Canadian-headquartered medical device company that develops wearable assistive eyewear for individuals with central vision loss and legal blindness. Its flagship product, eSight Go, is a wireless, hands-free headset that combines a high-speed, high-definition camera with proprietary real-time image-processing algorithms and dual Full HD (1920x1080) OLED displays to capture, optimize, and present enhanced video so the user's brain can synthesize images and fill central vision gaps. The device targets acuity ranges from 20/60 to 20/800 and addresses over 20 ocular conditions including macular degeneration, diabetic retinopathy, and Stargardt disease, with up to 24x magnification and a 45° field of view that preserves natural peripheral vision for mobility. Clinical efficacy is supported by peer-reviewed randomized controlled trials (the eQuest study at six institutions including Johns Hopkins and University of Montreal) showing a seven-line gain in distance visual acuity and 12-letter contrast improvement.

Short descriptiontext

eSight Corp develops eSight Go, a wearable assistive eyewear device that uses a high-definition camera and proprietary image-processing algorithms on dual OLED screens to enhance vision for individuals with central vision loss and legal blindness across 20+ eye conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
assistive vision technology, low vision eyewear, wearable medical devices, central vision loss, digital vision enhancement
Industry3 codes
1Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment)
CodeHLAHAJADPrimaryYes
2AR Smart Glasses
CodeCRACAIAEPrimaryNo
3Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)
CodeHDACALAHPrimaryNo
NAICS code2 codes
  • Ophthalmic Goods Manufacturing339115
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Ophthalmic Goods3851
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Assistive Vision Technology / Wearable Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1eSight Go Device Sales
TypeHardware Sales
Description

One-time sale of the eSight Go wearable assistive low-vision device (MSRP $4,950 USD / $6,600 CAD). Revenue is generated at point of purchase through direct sales, authorized distributors, and provider/clinic channels. Additional accessories and extra neck battery packs are available for separate purchase.

esighteyewear.com
2Home Experience Program Trial Fee
TypeOne Time License
Description

The Home Experience Program allows customers to try eSight Go for 7 days for $250 USD / $342 CAD. This fee is non-refundable but is deducted from the overall device cost if the customer purchases. This serves as both a revenue stream and a conversion mechanism.

esighteyewear.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details4 tiers
1eSight Go - Standard Device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

MSRP $4,950 USD / $6,600 CAD. Includes device, rechargeable neck battery pack, USB-C cables, remote control, AC power adapter, adjustable nose pieces, microfiber cleaning cloth, neck lanyard, protective carrying case, coaching sessions, free USPS Ground shipping, and 2-year limited warranty on device and neck battery (1 year on accessories).

esighteyewear.com
2Home Experience Trial Program
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$250 USD / $342 CAD for a 7-day at-home trial. Non-refundable but credited toward purchase if customer buys eSight Go. Trial fee is waived for patients referred by a provider or clinic.

esighteyewear.com
3Coaching Sessions
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Coaching sessions are included with device purchase. 1 session included with Home Experience Trial, 5 sessions included after device purchase. Conducted via Microsoft Teams video conferencing.

esighteyewear.com
4Shopify Financing
ModelSubscriptionBilling cadenceMonthly
Notes

Financing available through Shopify: 3-, 6-, or 12-month terms for US and Canadian residents ages 18+ with a US or Canadian shipping address. Additional restrictions apply.

esighteyewear.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1eSight Go
Description

The advanced digital device for low vision - a wireless, hands-free wearable assistive device designed to help people with central vision loss see more clearly, featuring HD OLED screens, up to 24x magnification, and 45-degree field of view.

esighteyewear.com
Core offering1 text field

eSight designs, manufactures, and sells the eSight Go wireless wearable assistive eyewear device, which combines a high-speed HD camera with proprietary smart algorithms and dual OLED screens to capture, enhance, and display real-time video so users with central vision loss can see faces, read, watch TV, and maintain mobility. The company complements the device with the Home Experience Program trial, eSight Coach personalized training, and a TeleHealth / Clinical Partner program for vision professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 7-line gain in distance visual acuity (from 20/177 baseline to 20/32 with device)
+5 more records
Product overview1 text field

eSight is a pioneer in assistive digital vision technology offering a unified product ecosystem centered on the eSight Go wearable electronic eyewear device for individuals with central vision loss and legal blindness. The portfolio includes the core eSight Go device (wireless, hands-free wearable with HD camera and OLED displays), the eSight Go Companion App (mobile add-on for additional functionality), and complementary services including eSight Coaches (personalized support from vision-impaired coaches), the Home Experience Program (7-day at-home trial), and TeleHealth Program (remote training via video conferencing). The company was acquired by Gentex Corporation in November 2023 and continues to develop next-generation wearable assistive vision technology. All products are designed to assist people with over 20 different eye conditions including macular degeneration, diabetic retinopathy, and Stargardt disease.

Product and service5 records
1eSight Go
CategoryWearable assistive vision device
Description

The primary wireless, hands-free wearable assistive digital device for individuals with significant central vision loss and legal blindness. eSight Go uses a high-speed HD camera and proprietary algorithms to capture, optimize, and display enhanced video on OLED screens in real time, helping users see more clearly and maintain mobility and independence.

2eSight Coach
CategoryCustomer support and training service
Description

Personalized support service where each customer is assigned an eSight Coach who has personal experience with vision impairment and uses eSight technology. Coaches provide device setup assistance, training, troubleshooting, and ongoing guidance through video conferencing sessions.

3Home Experience Program
CategoryTrial / pre-purchase service
Description

A remote learning and training program allowing customers to trial eSight Go in their home for 7 days before purchasing. Includes virtual consultation with an eSight specialist, in-home device evaluation, training sessions with an eSight Coach, and a non-refundable trial fee that is applied toward purchase.

4TeleHealth Program
CategoryRemote clinical service
Description

Remote training program for patients referred by healthcare providers. Includes virtual eligibility assessment, coordinated in-home device evaluation, and training on device usage, proven to improve patient quality of life through peer-reviewed randomized controlled trials.

5Clinical Partner Program
CategoryClinical referral / partnership program
Description

Partnership program for vision professionals and low vision clinics to refer patients to eSight. Enables healthcare providers to offer eSight as a treatment option with coordinated patient onboarding through the TeleHealth program.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

In January 2024, Gentex Corporation (NASDAQ: GNTX), a US-based electro-optical products company, acquired eSight Corp for an undisclosed sum. Gentex had previously partnered with eSight in January 2022 to develop next-generation wearable assistive eyewear. The acquisition combined Gentex's expertise in electro-optical products for automotive, aerospace, and fire protection industries with eSight's digital vision technology to advance next-generation wearable assistive eyewear for individuals with over 20 different ocular disorders. eSight now operates as a brand under Gentex Corporation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Johns Hopkins Medicine served as a clinical partner in the eQuest randomized controlled trial (ClinicalTrials.gov Identifier NCT02616900) that clinically validated eSight's efficacy. The study demonstrated a seven-line gain in distance acuity, 12-letter contrast improvement, and 100% mobility retention.

3University of Montreal
Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Montreal was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients. Researchers at the university contributed peer-reviewed publications on eSight's clinical performance.

esighteyewear.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UHN was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Michigan was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Center for Retina & Macular Disease was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Miami was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

OrCam MyEye and OrCam Read are AI-powered wearable assistive devices for visually impaired and blind users, competing head-to-head with eSight in the consumer low-vision device market with similar price points and direct-to-consumer distribution.

TypeDirect peer
Description

IrisVision offers wearable low-vision smart glasses using smartphone-based VR/AR hardware with magnification and contrast features, targeting the same central vision loss population as eSight with similar prescription-based sales models.

TypeDirect peer
Description

Eyedaptic develops AR glasses specifically designed for low-vision users with age-related macular degeneration and other retinal conditions, offering software-driven visual enhancement that competes directly with eSight's clinical value proposition.

TypeDirect peer
Description

NuEyes produces wearable smart glasses for the visually impaired using ODG and similar AR hardware platforms, targeting the same low-vision demographic and competing for clinical referrals from vision specialists.

TypeDirect peer
Description

Enhanced Vision is an established low-vision assistive device manufacturer offering desktop and head-worn magnification solutions; competes with eSight in clinical low-vision channels and serves overlapping ophthalmology and optometry referral networks.

TypeEmerging player
Description

Aira provides on-demand remote visual assistance via smart glasses and live agents, serving blind and low-vision users with subscription-based services that overlap with eSight's mobility and independence use cases.

TypeBroad incumbent
Description

Vuzix is an established enterprise smart glasses manufacturer whose waveguide-based display technology could be adapted for low-vision applications; competes indirectly as a broader wearables platform that may enter the assistive vision space.

TypeBroad incumbent
Description

Microsoft's HoloLens mixed reality platform includes accessibility research and enterprise AR applications that could be extended to low-vision use cases, representing a potential adjacent competitor with significant R&D resources.

TypeBroad incumbent
Description

Apple's Vision Pro spatial computing platform includes accessibility features for low-vision users; though priced higher than eSight, Apple's mainstream distribution and accessibility integration could pressure specialized assistive device vendors over time.

10Lighthouse International (low-vision services)
TypeOthers
Description

Lighthouse for the Blind and similar low-vision service organizations serve as both referral sources for eSight and competing providers of vision rehabilitation services, representing an ecosystem partner that could shift toward in-house device offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

eSight

Assistive Vision Technology / Wearable Medical Devicesesighteyewear.com

eSight Corp develops eSight Go, a wearable assistive eyewear device that uses a high-definition camera and proprietary image-processing algorithms on dual OLED screens to enhance vision for individuals with central vision loss and legal blindness across 20+ eye conditions.

What eSight does

eSight Corp is a Canadian-headquartered medical device company that develops wearable assistive eyewear for individuals with central vision loss and legal blindness. Its flagship product, eSight Go, is a wireless, hands-free headset that combines a high-speed, high-definition camera with proprietary real-time image-processing algorithms and dual Full HD (1920x1080) OLED displays to capture, optimize, and present enhanced video so the user's brain can synthesize images and fill central vision gaps. The device targets acuity ranges from 20/60 to 20/800 and addresses over 20 ocular conditions including macular degeneration, diabetic retinopathy, and Stargardt disease, with up to 24x magnification and a 45° field of view that preserves natural peripheral vision for mobility. Clinical efficacy is supported by peer-reviewed randomized controlled trials (the eQuest study at six institutions including Johns Hopkins and University of Montreal) showing a seven-line gain in distance visual acuity and 12-letter contrast improvement.

eSight firmographics

Firmographics
Name
eSight
Legal name
eSight Corp
Website
https://esighteyewear.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
eSight Corp develops eSight Go, a wearable assistive eyewear device that uses a high-definition camera and proprietary image-processing algorithms on dual OLED screens to enhance vision for individuals with central vision loss and legal blindness across 20+ eye conditions.
Ownership category
akta.pro rank

eSight industry classification

Industry
Product category
Assistive Vision Technology / Wearable Medical Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Ophthalmic Goods (3851), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)
akta.pro secondary industries
AR Smart Glasses (CRACAIAE), Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount) (HDACALAH)

Keywords

  • Assistive vision technology
  • Low vision eyewear
  • Wearable medical devices
  • Central vision loss
  • Digital vision enhancement

Where eSight is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

eSight business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. eSight Go Device Sales: One-time sale of the eSight Go wearable assistive low-vision device (MSRP $4,950 USD / $6,600 CAD). Revenue is generated at point of purchase through direct sales, authorized distributors, and provider/clinic channels. Additional accessories and extra neck battery packs are available for separate purchase.
  2. Home Experience Program Trial Fee: The Home Experience Program allows customers to try eSight Go for 7 days for $250 USD / $342 CAD. This fee is non-refundable but is deducted from the overall device cost if the customer purchases. This serves as both a revenue stream and a conversion mechanism.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goeSight Go - Standard Device
One time/ perpetual licensePay-as-you-goHome Experience Trial Program
One time/ perpetual licensePay-as-you-goCoaching Sessions
SubscriptionMonthlyShopify Financing

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

eSight product offering

Product offering

Core offering

eSight designs, manufactures, and sells the eSight Go wireless wearable assistive eyewear device, which combines a high-speed HD camera with proprietary smart algorithms and dual OLED screens to capture, enhance, and display real-time video so users with central vision loss can see faces, read, watch TV, and maintain mobility. The company complements the device with the Home Experience Program trial, eSight Coach personalized training, and a TeleHealth / Clinical Partner program for vision professionals.

Product overview

eSight is a pioneer in assistive digital vision technology offering a unified product ecosystem centered on the eSight Go wearable electronic eyewear device for individuals with central vision loss and legal blindness. The portfolio includes the core eSight Go device (wireless, hands-free wearable with HD camera and OLED displays), the eSight Go Companion App (mobile add-on for additional functionality), and complementary services including eSight Coaches (personalized support from vision-impaired coaches), the Home Experience Program (7-day at-home trial), and TeleHealth Program (remote training via video conferencing). The company was acquired by Gentex Corporation in November 2023 and continues to develop next-generation wearable assistive vision technology. All products are designed to assist people with over 20 different eye conditions including macular degeneration, diabetic retinopathy, and Stargardt disease.

Differentiator

Problem solved

Functional benefit

Brands

  • eSight Go: The advanced digital device for low vision - a wireless, hands-free wearable assistive device designed to help people with central vision loss see more clearly, featuring HD OLED screens, up to 24x magnification, and 45-degree field of view.

Products and services

  • eSight Go The primary wireless, hands-free wearable assistive digital device for individuals with significant central vision loss and legal blindness. eSight Go uses a high-speed HD camera and proprietary algorithms to capture, optimize, and display enhanced video on OLED screens in real time, helping users see more clearly and maintain mobility and independence.
  • eSight Coach Personalized support service where each customer is assigned an eSight Coach who has personal experience with vision impairment and uses eSight technology. Coaches provide device setup assistance, training, troubleshooting, and ongoing guidance through video conferencing sessions.
  • Home Experience Program A remote learning and training program allowing customers to trial eSight Go in their home for 7 days before purchasing. Includes virtual consultation with an eSight specialist, in-home device evaluation, training sessions with an eSight Coach, and a non-refundable trial fee that is applied toward purchase.
  • TeleHealth Program Remote training program for patients referred by healthcare providers. Includes virtual eligibility assessment, coordinated in-home device evaluation, and training on device usage, proven to improve patient quality of life through peer-reviewed randomized controlled trials.
  • Clinical Partner Program Partnership program for vision professionals and low vision clinics to refer patients to eSight. Enables healthcare providers to offer eSight as a treatment option with coordinated patient onboarding through the TeleHealth program.

Quantifiable outcome

  • 7-line gain in distance visual acuity (from 20/177 baseline to 20/32 with device)
  • +5 more outcomes

Companies that use eSight

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

eSight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature9 records

eSight partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • Gentex CorporationcoreStrategic or Co-development Partner · 1 January 2024In January 2024, Gentex Corporation (NASDAQ: GNTX), a US-based electro-optical products company, acquired eSight Corp for an undisclosed sum. Gentex had previously partnered with eSight in January 2022 to develop next-generation wearable assistive eyewear. The acquisition combined Gentex's expertise in electro-optical products for automotive, aerospace, and fire protection industries with eSight's digital vision technology to advance next-generation wearable assistive eyewear for individuals with over 20 different ocular disorders. eSight now operates as a brand under Gentex Corporation.
  • Johns Hopkins MedicinecoreStrategic or Co-development PartnerJohns Hopkins Medicine served as a clinical partner in the eQuest randomized controlled trial (ClinicalTrials.gov Identifier NCT02616900) that clinically validated eSight's efficacy. The study demonstrated a seven-line gain in distance acuity, 12-letter contrast improvement, and 100% mobility retention.
  • University of MontrealcoreStrategic or Co-development PartnerUniversity of Montreal was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients. Researchers at the university contributed peer-reviewed publications on eSight's clinical performance.
  • UHN (University Health Network)coreStrategic or Co-development PartnerUHN was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.
  • University of MichigancoreStrategic or Co-development PartnerUniversity of Michigan was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.
  • Center for Retina & Macular DiseasecoreStrategic or Co-development PartnerCenter for Retina & Macular Disease was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.
  • University of MiamicoreStrategic or Co-development PartnerUniversity of Miami was a clinical partner in the eQuest RCT study validating eSight's effectiveness for central vision loss patients.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

eSight competitors and assessment

Company assessment

Direct peers

  • OrCam Technologies: OrCam MyEye and OrCam Read are AI-powered wearable assistive devices for visually impaired and blind users, competing head-to-head with eSight in the consumer low-vision device market with similar price points and direct-to-consumer distribution.
  • IrisVision: IrisVision offers wearable low-vision smart glasses using smartphone-based VR/AR hardware with magnification and contrast features, targeting the same central vision loss population as eSight with similar prescription-based sales models.
  • Eyedaptic: Eyedaptic develops AR glasses specifically designed for low-vision users with age-related macular degeneration and other retinal conditions, offering software-driven visual enhancement that competes directly with eSight's clinical value proposition.
  • NuEyes Technologies: NuEyes produces wearable smart glasses for the visually impaired using ODG and similar AR hardware platforms, targeting the same low-vision demographic and competing for clinical referrals from vision specialists.
  • Enhanced Vision (by Optelec): Enhanced Vision is an established low-vision assistive device manufacturer offering desktop and head-worn magnification solutions; competes with eSight in clinical low-vision channels and serves overlapping ophthalmology and optometry referral networks.

Emerging players

  • Aira Tech Corp: Aira provides on-demand remote visual assistance via smart glasses and live agents, serving blind and low-vision users with subscription-based services that overlap with eSight's mobility and independence use cases.

Broad incumbents

  • Vuzix Corporation: Vuzix is an established enterprise smart glasses manufacturer whose waveguide-based display technology could be adapted for low-vision applications; competes indirectly as a broader wearables platform that may enter the assistive vision space.
  • Microsoft (HoloLens): Microsoft's HoloLens mixed reality platform includes accessibility research and enterprise AR applications that could be extended to low-vision use cases, representing a potential adjacent competitor with significant R&D resources.
  • Apple (Vision Pro): Apple's Vision Pro spatial computing platform includes accessibility features for low-vision users; though priced higher than eSight, Apple's mainstream distribution and accessibility integration could pressure specialized assistive device vendors over time.

Others

  • Lighthouse International (low-vision services): Lighthouse for the Blind and similar low-vision service organizations serve as both referral sources for eSight and competing providers of vision rehabilitation services, representing an ecosystem partner that could shift toward in-house device offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

eSight social profiles

Digital presence

eSight compliance and trust

Trust signal

Compliance3 records

eSight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

eSight leadership team

Management profile

Number of profiles

Profiles6 records

eSight funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

eSight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eSight

What does eSight do?

eSight designs, manufactures, and sells the eSight Go wireless wearable assistive eyewear device, which combines a high-speed HD camera with proprietary smart algorithms and dual OLED screens to capture, enhance, and display real-time video so users with central vision loss can see faces, read, watch TV, and maintain mobility. The company complements the device with the Home Experience Program trial, eSight Coach personalized training, and a TeleHealth / Clinical Partner program for vision professionals.

Is eSight a public or private company?

eSight is a private company. It is classified as corporate owned and is currently operating.

When was eSight founded?

eSight was founded in 2013. It employs 51 to 100 people.

Where is eSight based?

eSight is headquartered in Ottawa, Canada, in the North America region.

How does eSight make money?

Two revenue lines are on record. eSight Go Device Sales are the primary driver. The others are home Experience Program Trial Fee.

Who are eSight's main competitors?

Direct peers on record are OrCam Technologies, IrisVision, Eyedaptic, NuEyes Technologies and Enhanced Vision (by Optelec). Aira Tech Corp is listed as an emerging player. Broad incumbents are Vuzix Corporation, Microsoft (HoloLens) and Apple (Vision Pro). Lighthouse International (low-vision services) is listed as an others.

Does eSight have an API?

No public API is recorded for eSight.

What industry is eSight in?

eSight's product category is Assistive Vision Technology / Wearable Medical Devices. Its primary akta.pro industry code is HLAHAJAD, Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment), with a secondary code of CRACAIAE, AR Smart Glasses. Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GoogleeSight, Be My Eyes announce sweepstakes winnerShana Newton, a college student from Eugene, Oregon, won a Be My Eyes sweepstakes for an eSight 4 device. The wearable enhances her vision, allowing her to navigate campus and daily life without visual impairment. eSight and Be My Eyes announced the winner on the day of the announcement.openPR.comAnalysis of Key Market Segments Influencing the Assistive Technology for Low Vision MarketThe assistive technology for low vision market is forecasted to expand significantly, reaching a value of $1.71 billion by 2030 with a compound annual growth rate of 8.4%, driven by an aging global population, increased adoption of digital assistive devices, and breakthroughs in computer vision. In January 2024, Gentex Corporation, a US-based electro-optical products company, acquired eSight Corp, a Canadian wearable vision enhancement technology firm, for an undisclosed sum, aiming to combine their expertise to advance next-generation wearable assistive eyewear for individuals with over 20 different ocular disorders. Key market trends include wider adoption of AI-powered visual assistance tools, enhanced wearable devices, and stronger emphasis on personalized vision support.openPR.comFuture Perspectives: Key Trends Shaping the Low Vision and Blind Aids Products Market Until 2030The low vision and blind aids products market is projected to reach $5.46 billion by 2030, growing at a compound annual growth rate of 10.4%, driven by AI integration in vision aids, wearable technologies, and increasing demand for portable assistive devices. A notable development occurred in January 2024 when Gentex Corporation acquired eSight to improve wearable vision enhancement products using electro-optical engineering expertise. In August 2024, Eyedaptic launched EYE6 with Ivy, an AI-powered visual assistant for age-related macular degeneration supporting 99 languages.openPR.comKey Factors and Emerging Trends Shaping the Low Vision Assistive Devices Market LandscapeGentex Corporation acquired specific technology assets from eSight Corporation for approximately $88.9 million in January 2024, strengthening Gentex's portfolio of assistive technologies by incorporating eSight's advanced wearable vision products. The low vision assistive devices market is projected to reach $1.89 billion by 2030, growing at a compound annual growth rate of 9.0%, driven by AI-powered technologies, AR/VR integration, and expanding online sales channels. In July 2025, eSight launched the eSight Go wearable device featuring a 12-megapixel camera with 4K capability and dual HD OLED screens, supporting over 20 different types of vision impairments globally.Tech TimesFuture of Healthcare Tech: 10 Must-See CES 2026 Innovations Redefining AI Diagnostics and WearablesCES 2026 showcased a shift in healthcare technology toward practical, consumer-ready innovations including AI diagnostics and specialized wearables. Key products debuted by companies such as Withings, eSight, Petal AI, and Dephy focus on early detection, accessibility, and daily health monitoring without requiring clinical settings.SeedtableExplore 17 Best Assistive Technology Startups to watch in 2025. Discover innovative companies, funding insights, and industry trends.The article presents a curated list of 17 assistive technology startups for 2025, highlighting companies such as OrCam, Edmentum, eSight, and Cognixion. It provides specific details on their funding rounds, product offerings, and geographic locations.ForbesWhat Gentex’s Acquisition Of eSight Means For The Electronic Eyewear MarketGentex Corporation has acquired Toronto-based eSight Corp, a developer of electronic eyewear for the visually impaired, following a partnership that began in 2022. The acquisition aims to leverage Gentex’s manufacturing scale and supply chain power to reduce production costs and improve the eSight Go device, which is priced at $4,950. This move allows eSight to continue its ground-up hardware development strategy while competing against larger tech entrants in the assistive technology market.Daily Medical NewsGentex acquires eSight to advance development of eye wear technologyGentex Corp. has acquired eSight to develop and manufacture mobile electronic eyewear for individuals with vision impairments. This acquisition allows Gentex to leverage its automotive vision technology expertise to enhance the functionality and affordability of eSight's assistive devices. The move builds upon a partnership announced in January 2022 aimed at refining the device's design and performance.Eyes On EyecareGentex acquires eSight to develop next-gen electronic eyewearGentex Corporation has acquired eSight to develop and manufacture next-generation mobile electronic eyewear for visually impaired individuals. The acquisition aims to leverage Gentex's engineering and manufacturing capabilities to improve the functionality and affordability of eSight's vision enhancement devices. This strategic move is part of Gentex's expansion into the healthcare industry, with new products set to be showcased at CES 2024.GlobeNewswireGentex Announces eSight Acquisition Set to Showcase Advanced Vision Tech at CES 2024Gentex announced the acquisition of eSight, a vision enhancement company, to develop next-generation mobile electronic eyewear for people with visual impairments. The eyewear targets over 20 ocular disorders and will be showcased at CES 2024 in Las Vegas. The partnership aims to reduce device size and improve affordability.